192 related articles for article (PubMed ID: 30048985)
1. Myeloid Neoplasms with Germline Predisposition.
Geyer JT
Pathobiology; 2019; 86(1):53-61. PubMed ID: 30048985
[TBL] [Abstract][Full Text] [Related]
2. How I diagnose myeloid neoplasms with germline predisposition.
Patel N; Calvo KR
Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
[TBL] [Abstract][Full Text] [Related]
3. Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.
Reinig EF; Rubinstein JD; Patil AT; Schussman AL; Horner VL; Kanagal-Shamanna R; Churpek JE; Matson DR
Leukemia; 2023 Aug; 37(8):1589-1599. PubMed ID: 37393344
[TBL] [Abstract][Full Text] [Related]
4. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
5. [Myeloid neoplasms with germline predisposition].
Yoshida K
Rinsho Ketsueki; 2023; 64(9):949-954. PubMed ID: 37793870
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract][Full Text] [Related]
7. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
Sahoo SS; Kozyra EJ; Wlodarski MW
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
[TBL] [Abstract][Full Text] [Related]
8. Recognition of familial myeloid neoplasia in adults.
Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
[TBL] [Abstract][Full Text] [Related]
9. A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies.
Marquez R; Hantel A; Lorenz R; Neistadt B; Wong J; Churpek JE; Mardini NA; Shaukat I; Gurbuxani S; Miller JL; Godley LA
Leuk Lymphoma; 2014 Dec; 55(12):2945-6. PubMed ID: 24628296
[No Abstract] [Full Text] [Related]
10. [Current diagnosis of myeloproliferative neoplasms (2008 WHO classification)].
Frenkel' MA
Klin Lab Diagn; 2011 Jan; (1):43-9. PubMed ID: 21433318
[TBL] [Abstract][Full Text] [Related]
11. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
12. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract][Full Text] [Related]
13. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
Mandelker D; Zhang L; Kemel Y; Stadler ZK; Joseph V; Zehir A; Pradhan N; Arnold A; Walsh MF; Li Y; Balakrishnan AR; Syed A; Prasad M; Nafa K; Carlo MI; Cadoo KA; Sheehan M; Fleischut MH; Salo-Mullen E; Trottier M; Lipkin SM; Lincoln A; Mukherjee S; Ravichandran V; Cambria R; Galle J; Abida W; Arcila ME; Benayed R; Shah R; Yu K; Bajorin DF; Coleman JA; Leach SD; Lowery MA; Garcia-Aguilar J; Kantoff PW; Sawyers CL; Dickler MN; Saltz L; Motzer RJ; O'Reilly EM; Scher HI; Baselga J; Klimstra DS; Solit DB; Hyman DM; Berger MF; Ladanyi M; Robson ME; Offit K
JAMA; 2017 Sep; 318(9):825-835. PubMed ID: 28873162
[TBL] [Abstract][Full Text] [Related]
14. An analysis of the
Palmer D; Nacheva E
Leuk Lymphoma; 2021 May; 62(5):1255-1258. PubMed ID: 33349109
[No Abstract] [Full Text] [Related]
15. Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.
Hasserjian RP
Curr Opin Hematol; 2018 Mar; 25(2):120-128. PubMed ID: 29256927
[TBL] [Abstract][Full Text] [Related]
16. Cancer predisposition syndromes associated with myeloid malignancy.
Quinn E; Nichols KE
Semin Hematol; 2017 Apr; 54(2):115-122. PubMed ID: 28637615
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.
Kanagal-Shamanna R
Curr Hematol Malig Rep; 2021 Aug; 16(4):336-344. PubMed ID: 34028637
[TBL] [Abstract][Full Text] [Related]
18. Strategy for identification of a potential inherited leukemia predisposition in a 299 patient's cohort with tumor-only sequencing data.
Aguilera-Diaz A; Larrayoz MJ; Palomino-Echeverría S; Vazquez I; Ariceta B; Mañú A; Blasco-Iturri Z; Bernal Del Castillo T; Olivares Salaverri M; Olave Rubio MT; Rifon-Roca J; Alfonso-Pierola A; Prosper F; Fernandez-Mercado M; Calasanz MJ
Leuk Res; 2020 Aug; 95():106386. PubMed ID: 32512379
[TBL] [Abstract][Full Text] [Related]
19. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
20. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
